Siemens Healthineers AG (OTCMKTS:SMMNY) Sees Significant Drop in Short Interest

Siemens Healthineers AG (OTCMKTS:SMMNY) saw a large drop in short interest during the month of June. As of June 30th, there was short interest totaling 51,538 shares, a drop of 55.6% from the June 15th total of 116,151 shares. Based on an average daily volume of 345,299 shares, the days-to-cover ratio is currently 0.1 days.

Analysts Set New Price Targets

Separately, Zacks Research lowered Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Siemens Healthineers has a consensus rating of “Moderate Buy”.

Siemens Healthineers Trading Down 2.7%

OTCMKTS SMMNY opened at $19.54 on Wednesday. The business’s 50 day moving average is $19.87 and its two-hundred day moving average is $22.35. Siemens Healthineers has a 12-month low of $19.32 and a 12-month high of $28.92.

Siemens Healthineers (OTCMKTS:SMMNY) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.29 by $0.02. The business had revenue of $6.68 billion during the quarter, compared to analyst estimates of $6.96 billion.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.